Editor-in-Chief's Commentary: Integrating Economics Into Innovation.
In: Therapeutic Innovation & Regulatory Science, Jg. 47 (2013-07-01), Heft 4, S. 395-396
Online
academicJournal
Zugriff:
The author reflects on the economic factors affecting therapeutic innovation and regulatory science. These include risk and return, time frames to develop the product and recover investment costs, and affordability to patients. The author also recommends discussions on the funding of basic science in universities, ways to encourage investment in research and product development, and implementing prices for old and new medicines.
Titel: |
Editor-in-Chief's Commentary: Integrating Economics Into Innovation.
|
---|---|
Autor/in / Beteiligte Person: | Spielberg, Stephen P. |
Link: | |
Zeitschrift: | Therapeutic Innovation & Regulatory Science, Jg. 47 (2013-07-01), Heft 4, S. 395-396 |
Veröffentlichung: | 2013 |
Medientyp: | academicJournal |
ISSN: | 2168-4790 (print) |
DOI: | 10.1177/2168479013495839 |
Schlagwort: |
|
Sonstiges: |
|